First Command Bank’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-81
Closed -$9K 416
2017
Q3
$9K Hold
81
0.01% 344
2017
Q2
$8K Hold
81
0.01% 359
2017
Q1
$8K Hold
81
0.01% 340
2016
Q4
$7K Buy
+81
New +$7.37K 0.01% 341

Other funds holding IBB

First Command Bank's IBB Position: Q4 2017 in Review

First Command Bank sold out of iShares Biotechnology ETF (IBB) in Q4 2017, closing a stake of 81 shares — an estimated $9K sold.

First Command Bank first reported a position in IBB in Q4 2016 and held it in 4 quarters. The position peaked at $9K in Q3 2017. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • First Command Bank reported no remaining iShares Biotechnology ETF position as of Q4 2017 after selling out during the quarter.
  • First Command Bank sold 81 iShares Biotechnology ETF shares in Q4 2017, an estimated $9K.
  • First Command Bank first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 4 quarters.
  • First Command Bank's iShares Biotechnology ETF position peaked at $9K in Q3 2017.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on First Command Bank's 13F filing for Q4 2017, filed 12 Jan 2018.